Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile

Published : Dec-2017

No. of Pages : 81

order by fax Inquire before Buying request discount

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Trovagene Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Trovagene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Trovagene Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Trovagene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Trovagene Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 12
Trovagene Acquired Hybridoma Monoclonal Antibody Targeting the NPM1 Biomarker 14
Venture Financing 15
TrovaGene Secures USD15 Million in Venture Funding 15
Partnerships 16
Trovagene Enters Into Licensing Agreement with GenSignia IP 16
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 17
TrovaGene Enters into License Agreement for Hairy Cell Leukemia Biomarkers 18
TrovaGene Enters into License Agreement for Chronic Lymphoblastic Leukemia 19
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 20
Trovagene Enters into Licensing Agreement with Fairview Health Services 21
Trovagene Enters into Licensing Agreement with MLL Munchner Leukamielabor 22
Trovagene Enters into Agreement with Novogene 23
Trovagene Enters into Agreement for Trovera 24
Trovagene Enters into Agreement with AstraZeneca 25
Trovagene Enter into Agreements for Trovera 26
Trovagene Enters into Agreement with Boreal Genomics 27
Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center 28
Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center 29
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 30
Trovagene Enters into Patent Option Agreement with Massachusetts Institute of Technology 31
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 32
Equity Offering 33
Trovagene Files Registration Statement to Raise up to USD17.5 Million in Public Offering of Shares 33
Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants 34
Trovagene to Raise USD7 Million in Private Placement of Shares and Warrants 35
Trovagene Raises USD40.3 Million in Public Offering of Shares 36
Trovagene Completes Public Offering of Shares for USD23 Million 38
Trovagene Completes Private Placement Of Shares For US$15 Million 39
Trovagene Completes Private Placement Of Units For US$4 Million 40
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 41
Trovagene Inc - Key Competitors 42
Trovagene Inc - Key Employees 43
Trovagene Inc - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 45
Strategy And Business Planning 45
Aug 18, 2016: Blue Cross Blue Shield Illinois to cover Trovera liquid biopsy tests 45
Feb 22, 2016: Trovagene Enters into Preferred Provider Agreement with Fortified Provider Network 46
Feb 01, 2016: Trovagene Enters into Agreement with FedMed and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform 47
Jan 21, 2016: Trovagene Announces Agreement with America's Choice Provider Network to Offer Patients Access to its ctDNA Precision Cancer Monitoring Platform 48
Financial Announcements 49
Nov 09, 2017: Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results 49
Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results 51
May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results 53
Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results 55
Nov 09, 2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments 56
Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments 58
May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results 59
Mar 10, 2016: Trovagene Announces Fourth Quarter and Year End 2015 Financial Results 61
Corporate Communications 63
Sep 20, 2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis 63
Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 64
Apr 25, 2016: Trovagene Appoints Bill Welch as Chief Executive Officer 66
Mar 28, 2016: Trovagene Terminates the Employment of CEO Antonius Schuh and CFO Stephen Zaniboni for Cause 67
Legal and Regulatory 68
Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 68
Product News 69
Sep 09, 2016: Trovagene to Present at the 3rd Annual Precision Medicine Congress 69
May 19, 2016: Large Clinical Data Set in Lung Cancer Featuring Trovagene's Precision Cancer Monitoring Platform Selected for Oral Presentation at the 2016 ASCO Annual Meeting 70
Mar 24, 2016: Clinical Study Results Featuring Trovagene's Precision Cancer Monitoring Platform to be Presented at the AACR Annual Meeting 2016 71
Mar 08, 2016: Presentation at the Molecular Medicine Tri-Conference to Highlight Clinical Performance of Trovagene's Precision Cancer Monitoring Platform 72
Other Significant Developments 73
Jul 12, 2017: Trovagene Announces Agreement with Novogene for NextCollect in China 73
Jun 22, 2017: Trovagene Announces Agreement with Global Biopharmaceutical Company to Utilize Trovera ctDNA Tests and Services in Cancer Clinical Trials 74
Jan 12, 2017: Trovagene Announces Broadening Network of Commercial Distributors 75
Dec 13, 2016: Trovagene announces a reorganization to accelerate global distribution of liquid biopsy technology 76
Aug 17, 2016: BCBS Illinois expands patient access to Trovera tests for 8.1 million covered lives 77
Apr 11, 2016: Trovagene Enters Into Preferred Provider Agreement with Stratose PPO Network 78
Mar 01, 2016: Trovagene Enters Into Preferred Provider Agreement with Multiplan 79
Feb 24, 2016: Trovagene Enters into Preferred Provider Agreement with Three Rivers Provider Network 80
Appendix 81
Methodology 81
About GlobalData 81
Contact Us 81
Disclaimer 81

List of Tables
Trovagene Inc, Medical Equipment, Key Facts, 2016 2
Trovagene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Trovagene Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Trovagene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Trovagene Inc, Deals By Market, 2011 to YTD 2017 9
Trovagene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 12
Trovagene Acquired Hybridoma Monoclonal Antibody Targeting the NPM1 Biomarker 14
TrovaGene Secures USD15 Million in Venture Funding 15
Trovagene Enters Into Licensing Agreement with GenSignia IP 16
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 17
TrovaGene Enters into License Agreement for Hairy Cell Leukemia Biomarkers 18
TrovaGene Enters into License Agreement for Chronic Lymphoblastic Leukemia 19
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 20
Trovagene Enters into Licensing Agreement with Fairview Health Services 21
Trovagene Enters into Licensing Agreement with MLL Munchner Leukamielabor 22
Trovagene Enters into Agreement with Novogene 23
Trovagene Enters into Agreement for Trovera 24
Trovagene Enters into Agreement with AstraZeneca 25
Trovagene Enter into Agreements for Trovera 26
Trovagene Enters into Agreement with Boreal Genomics 27
Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center 28
Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center 29
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 30
Trovagene Enters into Patent Option Agreement with Massachusetts Institute of Technology 31
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 32
Trovagene Files Registration Statement to Raise up to USD17.5 Million in Public Offering of Shares 33
Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants 34
Trovagene to Raise USD7 Million in Private Placement of Shares and Warrants 35
Trovagene Raises USD40.3 Million in Public Offering of Shares 36
Trovagene Completes Public Offering of Shares for USD23 Million 38
Trovagene Completes Private Placement Of Shares For US$15 Million 39
Trovagene Completes Private Placement Of Units For US$4 Million 40
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 41
Trovagene Inc, Key Competitors 42
Trovagene Inc, Key Employees 43
Trovagene Inc, Subsidiaries 44

List of Figures
Trovagene Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 2
Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 2
Trovagene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 2
Trovagene Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 2
Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Trovagene Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Trovagene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Trovagene Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027